kynurenic acid (FS2)
/ BirchBioMed
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 02, 2025
U.S. FDA GRANTS BIRCHBIOMED ORPHAN DRUG DESIGNATION FOR FS2 IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
(PRNewswire)
Orphan drug • Idiopathic Pulmonary Fibrosis
1 to 1
Of
1
Go to page
1